Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 17, 2025 02:30 ET | Source: Alvotech

Mikil umframeftirspurn alþjóðlegra fjárfesta í útboði Alvotech á breytanlegra skuldabréfum að fjárhæð 108 milljónir dollara

REYKJAVÍK (17. DESEMBER 2025) - Alvotech (NASDAQ: ALVO, ALVO SDB) tilkynnti í dag að fyrirtækið hefði selt breytanleg skuldabréf að fjárhæð 108 milljónir bandaríkjadala til hóps um 20 alþjóðlegra...
December 17, 2025 02:30 ET | Source: Alvotech

Alvotech Successfully Places USD 108 Million Senior Unsecured Convertible Bonds in a Significantly Oversubscribed Offering

THIS PRESS RELEASE MAY NOT BE DISTRIBUTED, RELEASED, OR PUBLISHED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH...
December 16, 2025 11:48 ET | Source: Alvotech

Alvotech býður út breytanleg skuldabréf að fjárhæð 100 milljónir bandaríkjadala til að viðhalda fjárfestingu í lyfjaþróun, framleiðslu, markaðssetningu og styrkja lausafjárstöðu, staðfestir afkomuspá 2025 og birtir afkomuspá ársins 2026

REYKJAVÍK - (16. DESEMBER 2025) Alvotech (NASDAQ: ALVO, ALVO SDB) tilkynnti í dag að fyrirtækið efni til útboðs á breytanlegum skuldabréfum að fjárhæð 100 milljónir dollara með gjalddaga á árinu 2030....
December 16, 2025 11:48 ET | Source: Alvotech

Alvotech Launches $100 Million Senior Unsecured Convertible Bond Offering to Continue Strong Investment in R&D, Support Manufacturing, Global Product Launches and Enhance Liquidity Position, reaffirms 2025 outlook and provides 2026 guidance

THIS PRESS RELEASE MAY NOT BE DISTRIBUTED, RELEASED, OR PUBLISHED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH...
December 04, 2025 14:25 ET | Source: Robbins LLP

PRGO Class Action Reminder: Perrigo Company Stockholders Should Contact Robbins LLP for Information About Leading the Class Action Against PRGO

PRGO Class Action Reminder: Perrigo Company Stockholders Should Contact Robbins LLP for Information About Leading the Class Action Against PRGO
September 19, 2025 07:45 ET | Source: Alvotech

Markaðsleyfi veitt í Japan fyrir þrjár nýjar líftæknilyfjahliðstæður frá Alvotech

REYKJAVÍK 19. september 2025 - Alvotech (NASDAQ: ALVO, ALVO-SDB) tilkynnti í dag að japanska heilbrigðis-, atvinnu- og velferðarráðuneytið hafi veitt Fuji Pharma Co. Ltd. („Fuji Pharma“),...
September 19, 2025 07:45 ET | Source: Alvotech

Alvotech Announces Marketing Approval in Japan of Three New Biosimilars

REYKJAVIK, ICELAND (September 19, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today...
September 04, 2025 09:15 ET | Source: Alvotech

Alvotech tekur þátt í 23. árlegu heilbrigðisráðstefnu fjárfestingabankans Morgan Stanley í New York

Alvotech (NASDAQ: ALVO) tekur þátt í 23. árlegu heilbrigðisráðstefnu fjárfestingabankans Morgan Stanley, sem haldin verður dagana 8.-10. september nk., í New York. Fundir með fjárfestum verða haldnir...
September 04, 2025 09:15 ET | Source: Alvotech

Alvotech Meets Investors and Participates in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York

REYKJAVIK, Iceland, June 4, 2025 - Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its...
August 21, 2025 04:30 ET | Source: Alvotech

Advanz Pharma and Alvotech receive European approval for Mynzepli®, Biosimilar to Eylea®

Mynzepli® (aflibercept) is approved in all European Economic Area member countries for the treatment of various retinal diseases including neovascular (wet) age-related macular degeneration...